tcdb

navigate by keyword : antibody bezlotoxumab biological biosimilar biotech biotechnology clostridium difficile disease drug immunoglobulin immunology infection infusion injection inn mab monoclonal nomenclature peptide protein recurrence tcdb toxin

TcdB Toxin Cleaving Actin in Intestinal Epithelial Cell Royalty Free Stock Photo
ARECIFE, SPAIN - APRIL, 16 2017: AirBus A321 of ThomasCook.com w Royalty Free Stock Photo
ARECIFE, SPAIN - APRIL, 16 2017: AirBus A321 of ThomasCook.com w Royalty Free Stock Photo
ARECIFE, SPAIN - APRIL, 16 2017: AirBus A321 of ThomasCook.com w Royalty Free Stock Photo
ARECIFE, SPAIN - APRIL, 16 2017: AirBus A321 of ThomasCook.com w Royalty Free Stock Photo
   
   
Bezlotoxumab monoclonal antibody drug. Targets Clostridium difficile toxin B (TcdB) and is used in the treatment of recurrent C.
ARECIFE, SPAIN - APRIL, 16 2017: AirBus A321 of ThomasCook.com w Royalty Free Stock Photo
ARECIFE, SPAIN - APRIL, 16 2017: AirBus A321 of ThomasCook.com w Royalty Free Stock Photo
   
   
   
ARECIFE, SPAIN - APRIL, 16 2017: AirBus A321 of ThomasCook.com w Royalty Free Stock Photo
ARECIFE, SPAIN - APRIL, 16 2017: AirBus A321 of ThomasCook.com w Royalty Free Stock Photo
Bezlotoxumab monoclonal antibody drug. Targets Clostridium difficile toxin B (TcdB) and is used in the treatment of recurrent C. difficile infection. Generic name and stylized antibody representation


Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.